Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Atea Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Atea Pharmaceuticals

Atea Pharmaceuticals

Public

Boston-based Atea Pharmaceuticals, Inc. specializes in discovering oral antiviral therapies for global healthcare needs.

HQ
Boston, MA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in Boston, Atea Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of oral direct-acting antiviral therapies. The company's core mission is to address unmet medical needs in the global healthcare landscape, particularly through innovative antiviral treatments. Atea's flagship product, bemnifosbuvir, is an oral antiviral currently undergoing global Phase III trials for the treatment of COVID-19.

Atea Pharmaceuticals has garnered attention from notable investors and industry experts, contributing to its rapid progress and significant milestones. Key achievements include the successful enrollment of high-risk patients in their SUNRISE-3 trial for bemnifosbuvir. The company's impact is underscored by its commitment to advancing antiviral therapies, potentially transforming treatment paradigms for viral infections worldwide.

Atea Pharmaceuticals - Similar Companies

Antios Therapeutics logo

Antios Therapeutics

Enanta Pharmaceuticals logo

Enanta Pharmaceuticals

enanta.com

Chimerix logo

Chimerix

Atheric Pharmaceutical logo

Atheric Pharmaceutical

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Athenen Therapeutics logo

Athenen Therapeutics

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Areteia Therapeutics logo

Areteia Therapeutics

areteiatx.com

SIGA logo

SIGA

siga.com

Attune Pharmaceuticals logo

Attune Pharmaceuticals

Teva Pharmaceutical Industries logo

Teva Pharmaceutical Industries

tevapharm.com

Altesa logo

Altesa

altesabio.com

Aytu BioPharma logo

Aytu BioPharma

aytubio.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Aether Therapeutics logo

Aether Therapeutics

Atea Pharmaceuticals - Quick Facts

Who are Atea Pharmaceuticals' competitors?

Companies similar to Atea Pharmaceuticals include Antios Therapeutics, Enanta Pharmaceuticals, Chimerix and Atheric Pharmaceutical.

When was Atea Pharmaceuticals founded?

Atea Pharmaceuticals was founded in 2014.

Where is Atea Pharmaceuticals' headquarters located?

Atea Pharmaceuticals' headquarters is located in Boston, MA, US.

When was Atea Pharmaceuticals' last funding round?

Atea Pharmaceuticals' most recent funding round was for $215M (USD) in May 2020.

How much has Atea Pharmaceuticals raised to-date?

As of May 20, 2020, Atea Pharmaceuticals has raised a total of $283.4M (USD).

How many employees does Atea Pharmaceuticals have?

Atea Pharmaceuticals has 70 employees as of Feb 6, 2024.

Atea Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Antiviral Therapies
Tags
  • Healthtech
  • Pharmaceutical
Unique IDs
  • ein: 460574869
  • secCik: 0001593899
  • ticker: AVIR
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research